ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
G. R. Walton, J. C. Commander
Fusion Science and Technology | Volume 21 | Number 3 | May 1992 | Pages 2062-2066
Safety, Recycling, and Waste Management | doi.org/10.13182/FST92-A30025
Articles are hosted by Taylor and Francis Online.
The Tokamak Fusion Test Reactor (TFTR) Preliminary Decontamination and Decommissioning (D&D) Plan1 was developed to provide a framework for estimating the costs and schedule for implementing a final D&D Plan. This work will be used in evaluating the future use of the TFTR Test Cell. D&D planning and estimates were generated for two cases of plasma operations for TFTR. The first scenario is for continued operation in deuterium-deuterium (D-D) plasmas and subsequent decommissioning. This scenario would require D&D to a TFTR which is slightly activated and contaminated but still with a capability for “hands-on” D&D work. The second scenario calls for deuterium-tritium (D-T) plasma operations. In this scenario TFTR becomes highly activated and contaminated with tritium. This operational scenario will result in a TFTR which will require D&D involving remote handling. The end result in either scenario would provide a Test Cell which is available for future use. This paper will discuss the D&D objectives, management, safety and technical plans, and critical assumptions made in order to develop cost and schedule estimates.